Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Corcept Therapeutics Inc (CORT)

347 + Investors. Track Smart Money conviction in CORT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -40
Streak
2Q ▼
Buyers last Q
44%

Smart Money Signals — CORT

Based on 348 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds reduced or closed their CORT positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 82% of 3.0Y peak

82% of all-time peak
348 funds currently hold this stock — 82% of the 3.0-year high of 425 funds (reached 2025 Q1). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📉

Outflows — 18% fewer funds vs a year ago

fund count last 6Q
77 fewer hedge funds hold CORT compared to a year ago (-18% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟠

More sellers than buyers — 44% buying

185 buying239 selling
Last quarter: 239 funds reduced or exited vs 185 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~69 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 66 → 62 → 66 → 69. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

55% of holders stayed for 2+ years

■ 55% conviction (2yr+) ■ 25% medium ■ 20% new
193 out of 348 hedge funds have held CORT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
➡️

Steady discovery — ~69 new funds/quarter

111 → 66 → 62 → 66 → 69 new funds/Q
New funds entering each quarter: 66 → 62 → 66 → 69. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 63% veterans vs 25% newcomers

■ 63% veterans ■ 12% 1-2yr ■ 25% new
Entry-cohort mix of 364 holders: 231 (63%) are 2+ year veterans, 42 entered 1–2 years ago, and 91 (25%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 36% AUM from major funds

36% from top-100 AUM funds
50 of 346 holders rank in the top 100 by AUM, accounting for 36% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
2.9
out of 10
Low Exit Risk
Exit risk score 2.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CORT

In 2026 Q1, 185 hedge funds were net buyers of CORT (69 opened a new position, 116 added to an existing one), while 239 reduced or exited (130 trimmed, 109 sold completely) — a 44% buyer ratio, indicating roughly balanced activity. Net selling has persisted for two consecutive quarters. 36% of total institutional value in CORT is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -40 funds (more exits than new entries). Total institutional holders: 348.

Hedge Fund Ownership: CORT

How many hedge funds hold CORT — quarterly history vs. share price
Quarterly hedge fund ownership of CORT vs. share price

Market Analysis: CORT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CORT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Corcept Therapeutics Inc (CORT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much CORT has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 76d ago
CORT
+105.7%
XLV
+4.9%

CORT outperformed XLV by +100.8% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 31d ago
CORT
+47.1%
XLV
+6.0%

Since the filing became public, CORT outperformed XLV by +41.1% .

Interpretation: The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

29 top-rated funds 4 high-conviction
Consensus
6.4
/ 10
breadth
×
Elite
4.1
/ 10
conviction
Hedge Fund Positioning: CORT
347 + Investors

Track Smart Money conviction in CORT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 347 388 -10.57%
13F Shares 82M 83M -1.08%
Total Value $2.95B $2.87B 2.82%
New Positions 69 66 +3
Increased Positions 109 122 -13
Closed Positions 110 102 +8
Reduced Positions 127 150 -23
Total Calls 11 16 -31.25%
Total Puts 7 14 -50.0%
PUT/CALL Ratio 0.64 0.88 Bullish

Statistics: CORT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

347 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CORT. Verified SEC 13F-HR filings.

QUARTER:
Top 25 CORT holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Sio Capital Management, LLC 3.90% 674,759 $27.2M
2 Propel Bio Management, LLC 3.80% 147,828 $6.0M
3 Tang Capital Management LLC 3.07% 1,500,000 $60.5M
4 MPM BioImpact LLC 3.07% 985,700 $39.7M
5 Parallel Advisors, LLC 2.88% 3,977,404 $160.3M
6 Boxer Capital Management, LLC 1.32% 250,000 $10.1M
7 Hussman Strategic Advisors, INC. 1.10% 126,000 $5.1M
8 Diadema Partners LP 1.09% 158,500 $6.4M
9 Birchview Capital, LP 1.08% 47,200 $1.9M
10 S&T Bank/Pa 1.02% 68,087 $2.7M
11 FAS Wealth Partners, Inc. 0.81% 322,370 $13.0M
12 Bridge City Capital, LLC 0.61% 54,874 $2.2M
13 Illumine Investment Management, LLC 0.54% 17,524 $706K
14 Brown Capital Management LLC 0.54% 93,693 $3.8M
15 Soleus Capital Management, L.P. 0.47% 285,531 $11.5M
16 Focused Alpha, LLC 0.40% 32,421 $1.3M
17 Renaissance Technologies LLC 0.36% 5,682,783 $229.1M
18 Emerald Mutual Fund Advisers Trust 0.35% 179,607 $7.2M
19 Stanley-Laman Group, Ltd. 0.34% 68,625 $2.8M
20 Avidity Partners Management LP 0.32% 30,000 $1.4M
21 Emerald Advisers, LLC 0.26% 205,558 $8.3M
22 Kennedy Capital Management LLC 0.26% 304,615 $12.3M
23 Intellectus Partners, LLC 0.26% 31,000 $1.2M
24 Neo Ivy Capital Management 0.25% 23,505 $947K
25 Linden Thomas Advisory Services, LLC 0.24% 61,250 $2.5M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Corcept Therapeutics Inc (CORT)

What does the Smart Money Trend signal show for CORT?

Selling streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds reduced or closed their CORT positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for CORT?

More sellers than buyers — 44% buying: Last quarter: 239 funds reduced or exited vs 185 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for CORT holders?

Strong quality — 36% AUM from major funds: 50 of 346 holders rank in the top 100 by AUM, accounting for 36% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held CORT?

55% of holders stayed for 2+ years: 193 out of 348 hedge funds have held CORT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Corcept Therapeutics Inc (CORT) following the 2026 Q1 hedge fund 13F filings?

As of today, CORT has moved +47.1% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of +41.1%. Since the quarter end (March 31, 2026), CORT has gained +105.7% vs +4.9% for XLV. The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →